Tesamorelin 10mg

Tesamorelin Peptide is the research community's shorthand for Tesamorelin - the same compound listed on this page. If you searched for Tesamorelin Peptide, TH9507, Tesamorelin Acetate, this is that compound: Tesamorelin supplied as a 10mg lyophilised vial, third-party tested with a batch-specific Certificate of Analysis. For in-vitro research use only.

Tesamorelin is a synthetic peptide supplied by Pillar Research as Lyophilised powder for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as TH9507, Tesamorelin Acetate - all refer to the same compound.

Studied for how the growth-hormone pathway responds in laboratory models. More precisely, an unmodified GHRH(1-44) analogue - distinct from longer-acting analogues that add half-life-extension linkers. Tesamorelin is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied for how body composition behaves in published human research. More precisely, visceral fat and body composition, alongside changes in IGF-1 levels reflecting growth-hormone-axis activity.

Tesamorelin is commonly referred to as Tesamorelin Peptide in research communities and is sometimes searched for as TH9507, Tesamorelin Acetate - all refer to the same compound.

Tesamorelin (developmental code TH9507) is sometimes confused in search results with Sermorelin, a related but distinct and shorter-acting GHRH fragment - Pillar Research's listing is Tesamorelin specifically.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. Tesamorelin is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Each Pillar Research batch is third-party tested by HPLC and mass spectrometry, with the batch-specific Certificate of Analysis published for review before ordering - that certificate is the research record to judge.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which Tesamorelin is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

Tesamorelin (10mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. The batch-specific Certificate of Analysis is available to review before ordering. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. Each Tesamorelin batch is tested by Janoshik Analytical, an independent third-party laboratory, and the batch-specific Certificate of Analysis is published on this page before you order. Stock is held in Australia and dispatched the same business day.

Tesamorelin (10mg) is priced at A$129.99 per vial at Pillar Research. Yes. Tesamorelin is in stock at Pillar Research and orders placed before the dispatch cut-off leave from Australian stock the same business day. Batch Certificates of Analysis are available in our CoA library.

Tesamorelin is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add Tesamorelin 10mg (Tesamorelin Peptide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking the same business day when placed before the cut-off. A batch-specific Certificate of Analysis is included with every order.

Yes. Each released Tesamorelin 10mg (Tesamorelin Peptide) vial is linked to a batch-specific Certificate of Analysis (COA) so the stated purity, identity and batch record can be reviewed before ordering. Tesamorelin 10mg (Tesamorelin Peptide) is listed at 99.765% purity. Each released batch is independently analysed by HPLC for chromatographic purity and by mass spectrometry for identity.

No. Tesamorelin is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

Tesamorelin may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.